Cited by 174Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and PostpartumPrenatal Substance Exposure Effects

Prevalence and patterns of antidepressant drug use during pregnancy

Open access
Ververs, Tessa, Kaasenbrood, Hans, Visser, Gerard, Schobben, Fred, de Jong-van den Berg, Lolkje, Egberts, Toine·2006·European Journal of Clinical Pharmacology

Abstract

Objective The aim of this study was to determine the extent and patterns of antidepressant use before, during and after pregnancy in a large population in The Netherlands.Methods Health care records and prescription data from one of the largest Dutch health insurance companies were analysed. The study cohort consisted of 29,005 women who had live births in the period between January 2000 and July 2003. Antidepressant drug use during a specified period was defined as there being a record of a prescription during that period.Results During the first trimester of pregnancy 2% of all pregnant women of the study cohort were found to have taken antidepressants; in the second and third trimesters, this figure had dropped to 1.8% of all pregnancies. Antidepressant use before as well as during pregnancy was almost twofold higher in women over 35 years of age than in those under 35 years. Almost 60% of the women who used antidepressants before pregnancy stopped taking them in the first trimester, and a smaller number stopped thereafter. Of all women using antidepressants during pregnancy, one third started this medication during gestation. In the 3 months following delivery, the prevalence of antidepressant use was the same as before pregnancy (2.9%). There was no shift to benzodiazepines in the group of women who stopped taking antidepressants during pregnancy. Although paroxetine and fluoxetine were the most frequently used antidepressants among the study group, all modern antidepressants were used.Conclusion A considerable number of women are being exposed to antidepressants throughout pregnancy up until delivery. One consequence of this is that their newborns need special care and supervision during the first days of life. However, women who stop taking the medication may risk a relapse of their illness, and this may also have a negative effect on the child.

Integrity signals

Registry

Crossref · 10.1007/s00228-006-0177-0

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., de Jong-van den Berg, L., & Egberts, T.
Affiliations
University Medical Center Utrecht (NL)
Corresponding author
Egberts, Toine
Venue
European Journal of Clinical Pharmacology
Published
2006-08-08
Volume
62
Issue
10
Pages
863-870
ISSN
  • 0031-6970 (ISSN-L)
  • 1432-1041
OpenAlex
W2166028098
Cited by
174
References
26
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 3 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 8 · 2016: 11 · 2015: 11 · 2014: 15 · 2013: 23 · 2012: 10
FWCI
8.33
Type
journal article
Language
en
Open access
Locations
  • European Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
antidepressant use, pregnancy, maternal mental health, antidepressant discontinuation, first trimester, postpartum depression, paroxetine, fluoxetine, benzodiazepines, maternal age, prescribing patterns, neonatal care
MeSH terms
Adolescent, Adult, Age Factors, Antidepressive Agents, Benzodiazepines, Depressive Disorder, Drug Therapy, Combination, Female, Fluoxetine, Humans, Insurance, Pharmaceutical Services, Netherlands, Pregnancy, Pregnancy Complications, Pregnancy Trimesters, Drug Prescriptions, Time Factors, Prevalence, Databases, Factual, Paroxetine, Drug Utilization Review

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review